Chromatography Instruments Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Technique (Liquid Chromatography, Gas Chromatography, Supercritical Fluid Chromatography, Thin-Layer Chromatography, Ion-Exchange Chromatography, Others), By Application (Environmental Testing, Food And Beverage Analysis, Clinical Diagnostics, Life Sciences, Others), And By Geography - Forecasts From 2022 To 2027

  • Published : Nov 2022
  • Report Code : KSI061610592
  • Pages : 132

Chromatography Instruments Market is projected to witness a compound annual growth rate of 7.77% during the forecast period, reaching a total market size of US$13.440 billion in 2027 from US$7.961 billion in 2020.

Chromatography is a technique of separating the mixture by passing it in a solution or suspension through a medium in which the components move at different rates. Increasing demand for chromatography instruments is arising from their advantages during drug development and in the clinical research field. Other factors driving the growth of the chromatography instruments market include technological advancements in chromatography techniques, innovations in drug development, and increasing demand for environmental testing and food and beverage testing. Geographically, North America is projected to account for the largest market share in the projection period owing to the presence of major market players along with high investment in drug development in the region.

Growing chronic diseases and Illnesses to augment growth in the market

According to the Centres for Disease Control’s updates from September 2022 in the US, over 100 million adults were recorded to be suffering from either diabetes or prediabetes, and this number has only doubled over the last 5 years. Further, according to the Centre for Disease Control and Prevention’s updates from July 2021, illnesses from tick, flea, and mosquito bites had tripled, and nine novel vector-borne diseases were discovered. Hence, the increase in various illnesses and chronic diseases is projected to propel the demand for downstream processing, since chromatography columns are used to purify the product in downstream processing for drug development. Thus, the market is predicted to surge during the forecasted year.

North America is projected to hold a dominant share of the market

North America accounts for the biggest share of the chromatography instrumentation market due to factors like growing government investments and funding for R&D. Further, the presence of key participants in this region is projected to drive market growth. The countries here also have developed and well-structured healthcare systems that encourage research and development. These policies encourage global players to enter the US and Canada. Owing to their developed healthcare systems, these economies invest a high portion of their gross domestic product in research and development. Consequently, these countries get to witness the presence of several global market players and research laboratories, by using chromatography instrumentation. As the demand is fulfilled by the presence of global players in this region, the market is further forecasted to increase.

In February 2022, The Federal Trade Commission approved the Sartorius Stedim Biotech S.A.’s petition for prior approval of its acquisition of Novasep Process SAS’s Chromatography Equipment Business. Further, in May 2022, Agilent Technologies signed a collaborative agreement with APC Ltd., in which the companies agreed to combine their technologies to provide unique workflows to customers that support automated process analysis by liquid chromatography. Such acquisitions are projected to boost the growth of the market in the region.

Additionally, as per the American Cancer Society statistic updated in January 2022, cancer has continued to be the second most common cause of death in the US, after heart disease. A total of 1.9 million new cancer cases and 609,360 deaths from cancer were projected to occur in the US in 2022. The number is estimated to rise in the coming years due to the changing lifestyle of the people in the region. Thus, with the growing prevalence of cancer, chromatography instrumentation is being further adopted to develop a potent vaccine for cancer; hence, the market is likely to grow in the region.

Key Developments

  • In June 2022, Agilent Technologies launched a new LC-MS( liquid chromatography-mass spectrometry) and GC-MS (gas chromatography-mass spectrometry) quadrupole mass spectrometers that the company claimed will raise the level of built-in instrument intelligence and offer a much higher level of instrument diagnostics to maximize system up-time for the customers.
  • In June 2022, PerkinElmer, Inc. launched the GC 2400 Platform, which is an advanced, automated gas chromatography, headspace sampler, and GC/mass spectrometry solution designed to aid lab teams to simplify lab operations, drive accurate results, and perform more flexible monitoring.
  • In June 2020, Waters Corporation launched its new HPLC (high-performance liquid chromatography) - Waters Arc HPLC System.? The company claimed that the new liquid chromatography system could be used for routing testing in several end-use areas, such as the food and beverage industry, the pharmaceutical industry, as well as the academic and materials markets.

COVID-19 Insights

The COVID-19 pandemic had a positive effect on this market. Since the pharmaceutical and bioindustry sectors received a huge amount of attention during this period, it positively aided in the development of the gas chromatography market. In July 2020, the United States Air Force along with researchers from the University of Michigan collaborated to create modifications to an existing gas analysis system for it to work like a breathalyzer that could analyze the breath and detect the chemical signature of ARDS (acute respiratory distress syndrome) in its very nascent stages, which is a precursor to many COVID-19 infections. Developments such as these in this period positively aided market growth.

Chromatography Instruments Market Scope:


Report Metric Details
 Market Size Value in 2020  US$7.961 billion
 Market Size Value in 2027  US$13.440 billion
 Growth Rate  CAGR of 7.77% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments Covered  Technique, Application, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered Agilent Technologies, Phenomenex, Inc., Pall Corporation, JASCO, Inc., Shimadzu Corporation, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corporation
 Customization Scope  Free report customization with purchase



  • By Technique
    • Liquid Chromatography
    • Gas Chromatography
    • Supercritical Fluid Chromatography
    • Thin-Layer Chromatography
    • Ion-Exchange Chromatography
    • Others
  • By Application
    • Environmental Testing
    • Food and Beverage Analysis
    • Clinical Diagnostics
    • Life Sciences
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Others
    • Middle East and Africa (MEA)
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific (APAC)
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Taiwan
      • Others

Frequently Asked Questions (FAQs)

The chromatography instruments market is projected to reach a total market size of US$13.440 billion by 2027.
Chromatography Instruments Market was valued at US$7.961 billion in 2020.
The global chromatography instruments market is projected to witness a CAGR of 7.77% during the forecast period.
North America accounts for the largest share of the chromatography instruments market owing to the presence of major market players along with high investment in drug development in the region.
Increasing demand for chromatography instruments is arising from their advantages during drug development and in the clinical research field.


1.1. Market Overview

1.2. Covid-19 Scenario

1.3. Market Definition

1.4. Market Segmentation



2.1. Research Data

2.2. Assumptions



3.1. Research Highlights



4.1. Market Driver

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.3.1. Bargaining Power of End-Users

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis



5.1. Introduction

5.2. Liquid Chromatography

5.3. Gas Chromatography

5.4. Supercritical Fluid Chromatography

5.5. Thin-Layer Chromatography

5.6. Ion-Exchange Chromatography

5.7. Others



6.1. Introduction

6.2. Environmental Testing

6.3. Food and Beverage Analysis

6.4. Clinical Diagnostics

6.5. Life Sciences

6.6. Others



7.1. Introduction

7.2. North America

7.2.1. United States

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. UK

7.4.2. Germany

7.4.3. France

7.4.4. Italy

7.4.5. Spain

7.4.6. Others

7.5. Middle East and Africa (MEA)

7.5.1. Saudi Arabia

7.5.2. UAE

7.5.3. Isreal

7.5.4. Others

7.6. Asia Pacific (APAC)

7.6.1. Japan

7.6.2. China

7.6.3. India

7.6.4. Australia

7.6.5. South Korea

7.6.6. Indonesia

7.6.7. Thailand 

7.6.8. Taiwan

7.6.9. Others



8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix



9.1. Agilent Technologies

9.2. Phenomenex, Inc.

9.3. Pall Corporation

9.4. JASCO, Inc.

9.5. Shimadzu Corporation

9.6. Thermo Fisher Scientific, Inc.

9.7. PerkinElmer, Inc.

9.8. Waters Corporation

Agilent Technologies

Phenomenex, Inc.

Pall Corporation


Shimadzu Corporation

Thermo Fisher Scientific, Inc.

PerkinElmer, Inc.

Waters Corporation